Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in Patients With Coronavirus Disease 2019 - Zeng, Qing-Lei; Yu, Zu-Jiang; Gou, Jian-Jun; Li, Guang-Ming; Ma, Shu-Huan; Zhang, Guo-Fan; Xu, Jiang-Hai; Lin, Wan-Bao; Cui, Guang-Lin; Zhang, Min-Min; Li, Cheng; Wang, Ze-Shuai; et al. (The Journal of infectious diseases, 2020)
Keywords: Adult; Aged; Antibodies, Viral - therapeutic use; Betacoronavirus - genetics; Blood Donors; China; Coronaviridae; Coronavirus Infections - mortality; Coronavirus Infections - therapy; Coronavirus Infections - virology; Coronaviruses; COVID-19; Critical Illness; Female; Humans; Immunization, Passive - adverse effects; Male; Middle Aged; Pandemics; Plasma; Pneumonia, Viral - mortality; Pneumonia, Viral - therapy; Pneumonia, Viral - virology; Real-Time Polymerase Chain Reaction; Respiratory failure; Retrospective Studies; Ribonucleic acid; RNA; RNA, Viral - genetics; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; Survival Rate; Treatment Outcome; Virus Shedding - immunology; China; Fatality; Convalescent plasma therapy; Survival rate; Viral shedding; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Coronavirus disease 2019 (COVID-19)